ATC
GSK icon

Advantage Trust Company’s GSK GSK Stock Holding History

Advantage Trust Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+240
New +$12.7K ﹤0.01% 166
2025
Q4 		– Sell
-240
Closed -$10.4K – 147
2025
Q3 		$10.4K Hold
240
– – ﹤0.01% 168
2025
Q2 		$9.22K Buy
+240
New +$9.17K ﹤0.01% 187

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Advantage Trust Company's GSK Position: Q2 2026 in Review

Advantage Trust Company opened a new position in GSK (GSK) in Q2 2026: 240 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #166 among its holdings. This is a return to the name: Advantage Trust Company previously reported a position in GSK as recently as Q3 2025.

Advantage Trust Company first reported a position in GSK in Q2 2025 and has held it in 3 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Advantage Trust Company held 240 shares of GSK worth $12.6K as of Q2 2026.
  • GSK was a new Advantage Trust Company position in Q2 2026.
  • GSK made up ﹤0.01% of Advantage Trust Company's portfolio in Q2 2026, its #166 holding.
  • Advantage Trust Company first reported a position in GSK in Q2 2025 and has held it in 3 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.